F-star
 F-star Biotechnology Ltd. is a biotechnology company originally founded in Vienna with a current main research site in Cambridge UK. The company is focused in developing bispecific monoclonal antibodies using a modular combinatorial approach that engineers the Fc constant region of an immunoglobulin into a novel antigen-binding site.